Ahmed Mohammed Abd-Eldayem

PROFESSIONAL SUMMARY
  • March 2023 Associate professor pharmacology, Merit University, Egypt.       
  • September 2022 Assistant professor pharmacology, Merit University, Egypt.
  • September 2019 Assistant professor of pharmacology and Toxicology, Al-Ghad International Colleges for Applied Medical Sciences, Saudi
  • March 2017 Assistant professor of pharmacology and Toxicology, Faculty of Medicine, Assiut University, Assiut,
  • August 2008 Lecturer of Pharmacology and Toxicology, Faculty of Medicine, Assiut University, Assiut,
  • March 2001 Demonstrator of pharmacology and Toxicology, Faculty of Medicine, Assiut University, Assiut, Egypt
EXPERIENCE
  • Teaching pharmacology to students of the Faculty of Medicine and Pharmacy. Proven ability to engage learners actively during sessions and to support learner attainment which my references will
  • Experience in teaching clinical pharmacy students’ pharmacology, pharmacotherapy, and clinical
  • Excellent in dealing with all computer programs and
  • Experimental animal Drug administration to animals by different routes.
  • Isolation of organs and tissues for in vitro
  • Experience in dealing with different scientific laboratory
EDUCATION
  • 2017            Ph.D. in Pharmacology and ToxicologyMedical Pharmacology, Faculty of Medicine, Assiut University, Assiut, EgyptTitle: THE POSSIBLE EFFECTS OF GINKGO BILOBA EXTRACT ON RENAL FUNCTION IN HYPERTENSIVE AND HYPERCHOLESTEROLEMIC RATS.

  • 2008            MSc. Medical Pharmacology, Faculty of Medicine, Assiut University, Assiut, Egypt Title: Aptamers: New Approach in Therapeutics.

  • 1999            MBBCh, Faculty of Medicine, Assiut University, Assiut, Egypt

PUBLICATIONS
  • Can granulocyte     colony-stimulating      factor    (G-CSF)    ameliorate     acetaminophen-induced hepatotoxicity? (Human & Experimental Toxicology, IF= 903).
  • Valproate attenuates hypertonic glycerol-induced rhabdomyolysis and acute kidney injury (Néphrologie Thérapeutique, IF = 722).
  • Systemic and topical Ginkgo biloba leaf extract ameliorated rat paw inflammation in comparison to (Journal of Ethnopharmacology, IF = 4.36).
  • Protective effect of the standardized leaf extract of Ginkgo biloba (EGb761) against hypertension-induced renal injury in (Clinical and Experimental Hypertension, IF= 1.789)
  • The possible protective effects of vitamin D and L-carnitine against used atorvastatin-induced myopathy and (Comparative Clinical Pathology, IF= 0.97).
  • Protective effect of the standardized extract of Ginkgo Biloba (EGb761) against hypertension with hypercholesterolemia-induced renal injury in rats: Insights in the underlying mechanisms. (Biomedicine & Pharmacotherapy, IF= 529).
  • Formulation and Evaluation of Moxifloxacin HCl from Topical Gel Preparations. (Journal of American Science, 2017).
  • Chamomile is an anti-inflammatory in carrageenan-induced paw inflammation, (presented at Arab pharmacy Student Symposium, Assiut university, 2018).
  • The nephroprotective effects of ginkgo Biloba extract (EGb761) against l-NG-nitroarginine methyl ester-induced hypertension in rats: role of oxidative stress and inflammatory markers (J Curr Med Res Pract 1:79–85 © 2017 Faculty of Medicine, Assiut University).
  • Celecoxib has preventive and therapeutic benefits against nephrotoxicity caused by gentamicin in mice (Drug Research, 2022).
  • Therapeutic Potential of Mesenchymal Stem Cells versus Omega n-3 polyunsaturated fatty acids on gentamicin-induced cardiac degeneration (Pharmaceutics, 2022).
  • Anatabine attenuates ovalbumin-induced asthma via oxidative stress and inflammation mitigation and Nrf2/HO-1 signaling upregulation in rats (Life Sciences 308 (2022) 120954)
  • Molecular Detection of Listeria Species Isolated from Raw Milk with Special Reference to Virulence Determinants and Antimicrobial Resistance in Listeria monocytogenes (Journal of Animal Health and Production, 2022).